Among them, HLA-DMB [46], HLA-DRA [47], IL12A, and IL12B [48], whose determinant role in cancer outcome as immune adjuvants has already been published, are found in the top 500 TG2 positively correlating genes. The gene discussed is HLA-DMB; the disease is cancer.